颗粒蛋白前体通过抑制IL-6表达减轻哮喘气道炎症

doi:10.12047/j.cjap.6126.2021.050

摘要/Abstract

摘要： 目的: 探究颗粒蛋白前体(PGRN)在过敏性哮喘中的作用及机制。方法: 分别在野生鼠和IL-6 缺陷鼠中设置对照组和哮喘模型组,每组8只。模型组中,在第0日和第7日致敏小鼠(腹腔注射OVA 100 μg),从第14日起连续激发8 d(5％OVA雾化吸入,30 min/d,每日1次),末次激发24 h后取标本;对照组用PBS代替OVA做相同处理。采集支气管肺泡灌洗液(BALF)进行白细胞计数和分类计数;HE染色观察肺组织病理情况;Q-PCR及ELISA检测小鼠肺匀浆、血清和BALF中细胞因子水平。用IL-13刺激A549或BEAS-2B细胞建立体外哮喘炎症模型,每组3个复孔,共4组:PBS处理组、IL-13处理组、IL-13与重组人PGRN蛋白(rhPGRN)共同处理组及p38磷酸化抑制剂(SB203508)处理组。0 min~48 h后收集细胞及上清,用Q-PCR及ELISA检测PGRN和IL-6的表达;Western blot检测p38的磷酸化。结果: 与对照组相比,哮喘组小鼠肺匀浆和BALF中PGRN均显著降低(P＜ 0.01),血清PGRN有降低的趋势,然而哮喘小鼠BALF中IL-6显著升高(P＜0.05)。与野生鼠哮喘组相比,IL-6缺陷鼠哮喘组BALF中白细胞总数降低(P＜0.05),中性粒细胞数降低(P＜0.05),PGRN显著升高(P＜0.05),肺部病理损伤也减轻。体外实验中,IL-13处理组与PBS处理组相比,PGRN显著降低(P＜0.05),IL-6显著增高(P＜ 0.05),p38的磷酸化增加;p38抑制剂处理组比未处理组中IL-6水平降低(P＜0.05)。IL-13与rhPGRN共同处理组的IL-6显著低于IL-13处理组(P＜0.05),p38的磷酸化降低(P＜0.05)。结论: PGRN通过抑制p38磷酸化降低IL-6水平从而减轻哮喘小鼠气道炎症。

关键词: 小鼠, 哮喘, 气道炎症, 颗粒蛋白前体, 白介素6

Abstract: Objective: To investigate the role and mechanism of progranulin (PGRN) in asthma. Methods: Control group and model group were set up in wild and IL-6 knockout (IL-6 ko) mice, respectively. For asthma model, mice were intraperitoneally sensitized with 100 μg OVA on days 0 and 7, followed by aerosol challenges with 5% OVA for 30 min per day from day 14 to 21, and mice were sacrificed 24 h after the last challenge. The mice in control group were treated in the same way with PBS. Bronchoalveolar lavage fluid (BALF) was collected for leukocytes count and differential count. The pathological changes of lung tissues were observed by H&E staining. The cytokines in lung homogenate, serum and BALF were detected by Q-PCR and ELISA. The in vitro model of asthma was induced by stimulating A549 or BEAS-2B cells with IL-13. Each group was replicated in three wells and four groups were designed: PBS group, IL-13 treatment group, IL-13 + rhPGRN treatment group, inhibitors of p38 phosphorylation (SB203508) treatment group. The cells or supernatant were collected after 0~48 h. PGRN and IL-6 levels were determined by Q-PCR and ELISA, the level of p38 phosphorylation was tested by Western blot (WB). Results: Compared with control group, PGRN levels were decreased in lung homogenate and BALF (P＜0.05), and PGRN presented a downtrend in serum, however, the level of IL-6 in BALF was increased in asthma mice (P＜0.01). In IL-6 ko asthma mice, compared with the wild asthma mice, leukocytes, especially neutrophils in BALF were decreased (P＜0.05), but PGRN was increased (P＜0.05), lung pathological damage was significantly alleviated. In vitro experiments, compared with PBS group, PGRN level was decreased (P＜0.05), IL-6 level was increased (P＜0.01), phosphorylation of p38 was activated in IL-13 treatment group. Compared with IL-13 treatment group, in IL-13 + PGRN treatment group, IL-6 level was decreased (P＜0.05); phosphorylation of p38 was inhibited (P＜0.05); and the production of IL-6 (P＜0.05) was decreased after treatment with inhibitor of p38 phosphorylation. Conclusion: PGRN inhibited the production of IL-6 by suppressing the p38 phosphorylation to alleviate asthmatic airway inflammation.

Key words: mice, asthma, airway inflammation, PGRN, interleukin-6

中图分类号:

R392.8

齐玉红, 孙思, 王玲, 杨静, 吴光英, 黄琪, 胥文春. 颗粒蛋白前体通过抑制IL-6表达减轻哮喘气道炎症[J]. 中国应用生理学杂志, 2021, 37(4): 423-428.

QI Yu-hong, SUN Si, WANG Ling, YANG Jing, WU Guang-ying, HUANG Qi, XU Wen-chun. Progranulin attenuated asthma inflammation by inhibiting the expression of IL-6[J]. CJAP, 2021, 37(4): 423-428.

参考文献 21

[1]	Chiba Y, Danno S, Suto R, et al. Intranasal administration of recombinant progranulin inhibits bronchial smooth muscle hyperresponsiveness in mouse allergic asthma [J]. Am J Physiol Lung Cell Mol Physiol, 2018, 314 (1): L215 -L223.
[2]	黄闯, 黄琨. 颗粒蛋白前体在炎症性疾病中的作用研究进展[J]. 细胞与分子免疫学杂志, 2016, 32(2): 268-271.
[3]	Park SY, Hong GH, Park S, et al. Serum progranulin as an indicator of neutrophilic airway inflammation and asthma severity[J]. Ann Allergy Asthma Immunol, 2016, 117(6): 646-650.
[4]	Choi GS, Trinh HKT, Yang EM, et al. Role of clusterin/progranulin in toluene diisocyanate-induced occupational asthma[J]. Exp Mol Med, 2018, 50(5): 1-10.
[5]	Hasegawa T, Uga H, Mori A, et al. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma[J]. Eur Cytokine Netw, 2017, 28(1): 8-18.
[6]	Li X, Hastie AT, Peters MC, et al. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma[J]. J Allergy Clin Immunol, 2020, 145(1): 430-433.
[7]	Tian R, Li Y, Yao X, et al. PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt/β-catenin signaling pathway[J]. Inflammation, 2016, 39(4): 1387-1394.
[8]	Wang C, Zhang L, Ndong JC, et al. Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice[J]. Neuroinflammation, 2019, 16 (1): 238-250.
[9]	Walker W, Healey GD, Hopkin JM, et al. RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells[J]. Immunology, 2009, 127(2): 256-266.
[10]	Yuan F, Liu R, Hu M, et al. JAX2, an ethanol extract of Hyssopus cuspidatus Boriss, can prevent bronchial asthma by inhibiting MAPK/NF-kappaB inflammatory signaling[J]. Phytomedicine, 2018, 57: 305-314.
[11]	Ungurs MJ, Sinden NJ, Stockley RA, et al. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD [J]. Am J Physiol Lung Cell Mol Physiol, 2014, 306(1): L80-87.
[12]	Yin F, Banerjee R, Thomas B, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice[J]. J Exp Med, 2010, 207(1): 117-128.
[13]	Koo DH, Park CY, Lee ES, et al. Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study[J]. PLoS One, 2012, 7(6): e39880-39885.
[14]	Zhou J, Gao G, Crabb JW, et al. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line[J]. J Biol Chem, 1993, 268 (15): 10863-10869.
[15]	Qiu F, Song L, Ding F, et al. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus[J]. Diagn Pathol, 2013, 8 (1): 88-95.
[16]	Yamamoto Y, Takemura M, Serrero G, et al. Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis[J]. Inflammation, 2014, 37(5): 1806-1813.
[17]	Zou S, Luo Q, Song Z, et al. Contribution of progranulin to protective lung immunity during bacterial pneumonia[J]. J Infect Dis, 2017, 215(11): 1764-1773.
[18]	Vanaudenaerde BM, Wuyts WA, Dupont LJ, et al. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome[J]. J Heart Lung Transplant, 2003, 22(11): 1280-1283.
[19]	Kishimoto T. IL-6: from its discovery to clinical applications[J]. Int Immunol, 2010, 22(5): 347-352.
[20]	江宏志, 吴为群, 严英硕, 等. 几种常见呼吸道疾病行气道反应性检测的临床意义[J]. 新医学, 2004, 35(11): 683-684.
[21]	Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases[J].Int J Biol Sci, 2012, 8 (9): 1281-1290.